Senseonics Holdings (SENS) Research & Development (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Research & Development came in at $11.6 million in Q2 2026, up 50.86% year-over-year from $7.7 million in Q2 2025, and up 35.16% quarter-over-quarter from $8.6 million in Q1 2026.
Analysis
Senseonics Holdings (SENS) Research & Development (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Research & Development for 12 consecutive years, with $11.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development rose 50.86% year-over-year to $11.6 million in Q2 2026; TTM through Jun 2026 was $36.8 million, a 5.46% increase from a year earlier, with the FY2025 full-year figure at $31.6 million, down 23.22% from the prior year.
- Research & Development was $11.6 million for Q2 2026 at Senseonics Holdings, up from $8.6 million in the prior quarter.
- Over five years, Research & Development peaked at $12.8 million in Q2 2023 and troughed at $7.3 million in Q1 2025.
- A 5-year average of $10.1 million and a median of $10.5 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 58.96% in 2023 and slumped 30.07% in 2025, its largest moves.
- Over 5 years, Research & Development stood at $11.6 million in 2022, then retreated by 7.58% to $10.7 million in 2023, then dropped by 12.92% to $9.4 million in 2024, then retreated by 5.78% to $8.8 million in 2025, then jumped by 31.98% to $11.6 million in 2026.
- The last three Research & Development figures came in at $11.6 million (Q2 2026), $8.6 million (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Senseonics Holdings | 507.86 Mn | 267.25 Mn | 8.56 Mn | 11.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.64 Mn |
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 8.82 Mn |
| Sep 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 9.36 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.44 Mn |
| Dec 31, 2023 | 10.75 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 12.83 Mn |
| Mar 31, 2023 | 12.41 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 10.99 Mn |
| Jun 30, 2022 | 9.30 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.20 Mn |